Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1990 Dec;58(12):4153–4155. doi: 10.1128/iai.58.12.4153-4155.1990

Effects of recombinant human interleukin-1 beta on accumulation of inflammatory peritoneal macrophages in mice treated with pertussis toxin.

D Torre 1, F Speranza 1, A Pugliese 1, R Tambini 1
PMCID: PMC313790  PMID: 2254036

Abstract

In this study we report that treatment with recombinant human interleukin-1 beta (rIL-1 beta) (10 U per mouse, intraperitoneally) significantly increased the number of inflammatory macrophages in the peritoneal cavity of mice treated with pertussis toxin (PT) (1 micrograms per mouse, intravenously). The administration of rIL-1 beta in a single intraperitoneal dose (10 U per mouse) 1 or 2 days before challenge with PT did not prevent the decrease in the number of inflammatory macrophages in the peritoneal cavity of mice. On the other hand, the simultaneous administration of rIL-1 beta and PT, as well as the administration of rIL-1 beta 24 h after injection of PT, significantly counteracted the inhibitory effect of PT on inflammatory peritoneal macrophages.

Full text

PDF
4153

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Confer D. L., Eaton J. W. Phagocyte impotence caused by an invasive bacterial adenylate cyclase. Science. 1982 Sep 3;217(4563):948–950. doi: 10.1126/science.6287574. [DOI] [PubMed] [Google Scholar]
  2. Cybulsky M. I., Colditz I. G., Movat H. Z. The role of interleukin-1 in neutrophil leukocyte emigration induced by endotoxin. Am J Pathol. 1986 Sep;124(3):367–372. [PMC free article] [PubMed] [Google Scholar]
  3. Czuprynski C. J., Brown J. F. Purified human and recombinant murine interleukin-1 alpha induced accumulation of inflammatory peritoneal neutrophils and mononuclear phagocytes: possible contributions to antibacterial resistance. Microb Pathog. 1987 Nov;3(5):377–386. doi: 10.1016/0882-4010(87)90007-6. [DOI] [PubMed] [Google Scholar]
  4. Czuprynski C. J., Brown J. F. Recombinant murine interleukin-1 alpha enhancement of nonspecific antibacterial resistance. Infect Immun. 1987 Sep;55(9):2061–2065. doi: 10.1128/iai.55.9.2061-2065.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Czuprynski C. J., Brown J. F., Young K. M., Cooley A. J., Kurtz R. S. Effects of murine recombinant interleukin 1 alpha on the host response to bacterial infection. J Immunol. 1988 Feb 1;140(3):962–968. [PubMed] [Google Scholar]
  6. Dinarello C. A. Interleukin-1. Rev Infect Dis. 1984 Jan-Feb;6(1):51–95. doi: 10.1093/clinids/6.1.51. [DOI] [PubMed] [Google Scholar]
  7. Larsson E. L., Iscove N. N., Coutinho A. Two distinct factors are required for induction of T-cell growth. Nature. 1980 Feb 14;283(5748):664–666. doi: 10.1038/283664a0. [DOI] [PubMed] [Google Scholar]
  8. Levine S., Sowinski R. Inhibition of macrophage response to brain injury. A new effect of pertussis vaccine possibly related to histamine-sensitizing factor. Am J Pathol. 1972 May;67(2):349–360. [PMC free article] [PubMed] [Google Scholar]
  9. Meade B. D., Kind P. D., Ewell J. B., McGrath P. P., Manclark C. R. In vitro inhibition of murine macrophage migration by Bordetella pertussis lymphocytosis-promoting factor. Infect Immun. 1984 Sep;45(3):718–725. doi: 10.1128/iai.45.3.718-725.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Meade B. D., Kind P. D., Manclark C. R. Lymphocytosis-promoting factor of Bordetella pertussis alters mononuclear phagocyte circulation and response to inflammation. Infect Immun. 1984 Dec;46(3):733–739. doi: 10.1128/iai.46.3.733-739.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Ozaki Y., Ohashi T., Minami A., Nakamura S. Enhanced resistance of mice to bacterial infection induced by recombinant human interleukin-1a. Infect Immun. 1987 Jun;55(6):1436–1440. doi: 10.1128/iai.55.6.1436-1440.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Pearson R. D., Symes P., Conboy M., Weiss A. A., Hewlett E. L. Inhibition of monocyte oxidative responses by Bordetella pertussis adenylate cyclase toxin. J Immunol. 1987 Oct 15;139(8):2749–2754. [PubMed] [Google Scholar]
  13. Philip R., Epstein L. B. Tumour necrosis factor as immunomodulator and mediator of monocyte cytotoxicity induced by itself, gamma-interferon and interleukin-1. Nature. 1986 Sep 4;323(6083):86–89. doi: 10.1038/323086a0. [DOI] [PubMed] [Google Scholar]
  14. Sauder D. N., Mounessa N. L., Katz S. I., Dinarello C. A., Gallin J. I. Chemotactic cytokines: the role of leukocytic pyrogen and epidermal cell thymocyte-activating factor in neutrophil chemotaxis. J Immunol. 1984 Feb;132(2):828–832. [PubMed] [Google Scholar]
  15. Torre D., Pugliese A., Quadrelli C., Speranza F., Sampietro C. Cyclic AMP levels in lung and spleen tissue of mice treated with pertussis toxin. Microbiologica. 1989 Jan;12(1):29–33. [PubMed] [Google Scholar]
  16. Utsumi S., Sonoda S., Imagawa T., Kanoh M. Polymorphonuclear leukocyte-inhibitory factor of Bordetella pertussis. I. Extraction and partial purification of phagocytosis- and chemotaxis-inhibitory activities. Biken J. 1978 Dec;21(4):121–135. [PubMed] [Google Scholar]
  17. Vistica B. P., McAllister C. G., Sekura R. D., Ihle J. N., Gery I. Dual effects of pertussis toxin on lymphoid cells in culture. Cell Immunol. 1986 Aug;101(1):232–241. doi: 10.1016/0008-8749(86)90200-5. [DOI] [PubMed] [Google Scholar]
  18. Weiss A. A., Hewlett E. L. Virulence factors of Bordetella pertussis. Annu Rev Microbiol. 1986;40:661–686. doi: 10.1146/annurev.mi.40.100186.003305. [DOI] [PubMed] [Google Scholar]
  19. Zucali J. R., Dinarello C. A., Oblon D. J., Gross M. A., Anderson L., Weiner R. S. Interleukin 1 stimulates fibroblasts to produce granulocyte-macrophage colony-stimulating activity and prostaglandin E2. J Clin Invest. 1986 Jun;77(6):1857–1863. doi: 10.1172/JCI112512. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES